abstract |
A combination is described comprising N- (3-methoxy-5-methylpyrazin -2-yl) -2 - (4- [1,3,4-oxadiazol -2-yl] phenyl) pyridine-3-sulfone-mida, or a salt thereof, acceptable for pharmaceutical use, and an LHRH analog, and / or a bisphosphonate. |